BamSEC and AlphaSense Join Forces
Learn More

Coya Therapeutics Inc. – Material Contracts

NASDAQ: COYA    
Share price (9/9/26): $4.61    
Market cap (9/9/26): $108 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 10 pages Separation and General Release Agreement
12/34/56
EX-10.1
from 8-K 43 pages Securities Purchase Agreement
12/34/56
EX-10.11
from 10-K 5 pages Second Amendment to Sponsored Research Agreement
12/34/56
EX-10.10
from 10-K 6 pages First Amendment to Sponsored Research Agreement
12/34/56
EX-10.9
from 10-K 19 pages Sponsored Research Agreement
12/34/56
EX-10.2
from 8-K 11 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 10 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 51 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 7 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 2 pages First Amendment to Development and License Agreement
12/34/56
EX-10.1
from 8-K 59 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 1 page First Amendment to the Amended and Restated Coya Therapeutics, Inc. 2021 Equity Incentive Plan Adopted by the Compensation Committee of the Board of Directors: March 19, 2024 Approved by Stockholders: May 8, 2024
12/34/56
EX-10.18
from 10-K 60 pages Development and License Agreement
12/34/56
EX-10.1
from 8-K 51 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 9 pages Amended and Restated Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 8 pages Executive Employment Agreement
12/34/56
EX-10
from 10-Q 31 pages License and Supply Agreement
12/34/56
EX-10.15
from S-1/A 9 pages Coya Therapeutics, Inc. Stock Option Grant Notice
12/34/56
EX-10.12
from S-1/A 53 pages License Agreement by and Between Coya Therapeutics, Inc. and Arscience Biotherapeutics Inc. License Agreement
12/34/56
EX-10.11
from S-1/A 9 pages Material Transfer and Option Agreement Carnegie Mellon University – Coya Therapeutics
12/34/56